Live feed
Filing
SC 13G/A
SC 13G/A0001144204-15-066644·Arch Therapeutics, Inc.
Schedule 13G ownership disclosure
Arch Therapeutics, Inc.
Security class unavailable · CUSIP: 03939W109
Event date: 2015-10-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,500,961
- Percent of class
- 6.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-066644
- Form type
- SC 13G/A
- Filer
- Arch Therapeutics, Inc.
- CIK
- CIK 1537561
- Filed
- Nov 18, 2015
- Reporting period
- Oct 26, 2015
- Description
- Schedule 13G beneficial ownership